Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 13

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 13
---
31, 2024 that would have been structurally senior to the notes. At December 31, 2024, AMS Europe had outstanding approximately $5,157 million of unsecured indebtedness and no secured indebtedness.

#### Covenants
AMS Europe will issue the notes under an indenture containing covenants for your benefit. These covenants will restrict the ability, with certain exceptions, of:

•

Boston Scientific and AMS Europe to merge or consolidate with another entity or transfer all or substantially all of their respective property and assets; and

•

Boston Scientific and its Subsidiaries (as defined in the indenture) to create, grant or incur liens.

These covenants are subject to important exceptions and qualifications, as described under the headings “Description of Debt Securities — Merger, Consolidation, or Sale of Assets” and “Description of Debt Securities — Limitation on Liens” in the accompanying prospectus.

#### Additional Notes
AMS Europe may, without notice or consent of the holders of any series of notes, create and issue further notes ranking equally and ratably in all respects with the notes of any series, so that such further notes will be consolidated and form a single series with the corresponding series of notes and will have the same terms as to status, redemption or otherwise as the corresponding series of notes, subject to certain tax considerations.

#### Listing: No Active Trading Market
Application will be made for the notes to be admitted to the Official List of Euronext Dublin and to trading on the Global Exchange Market thereof. The listing application will be subject to approval by Euronext Dublin. The Global Exchange Market is not a regulated market within the meaning of MiFID II. There can be no assurance that the notes of any series will be admitted to the Official List of Euronext Dublin or admitted to trading on the Global Exchange Market. AMS Europe currently expects the notes to be admitted to the Official List of Euronext Dublin and to trading on the Global Exchange Market within 30 days after the original issue date. If such a listing is obtained, AMS Europe has no obligation to maintain such listing, and AMS Europe may delist the notes of any series at any time.

The notes of each series will be new securities for which there is currently no market. Although the underwriters have informed AMS Europe that they currently intend to make a market in the notes of each series, they are not obligated to do so and may discontinue market making at any time without notice. Accordingly, AMS Europe